Dimensional Fund Advisors’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50M | Buy |
1,582,176
+357,382
| +29% | +$11.3M | 0.01% | 1497 |
|
|
2025
Q1 | $40.7M | Buy |
1,224,794
+11,765
| +1% | +$390K | 0.01% | 1581 |
|
|
2024
Q4 | $41.7M | Buy |
1,213,029
+160,490
| +15% | +$5.52M | 0.01% | 1616 |
|
|
2024
Q3 | $42.1M | Buy |
1,052,539
+95,754
| +10% | +$3.83M | 0.01% | 1607 |
|
|
2024
Q2 | $28.9M | Buy |
956,785
+112,197
| +13% | +$3.39M | 0.01% | 1774 |
|
|
2024
Q1 | $28.4M | Buy |
844,588
+108,320
| +15% | +$3.64M | 0.01% | 1810 |
|
|
2023
Q4 | $23.8M | Sell |
736,268
-48,176
| -6% | -$1.56M | 0.01% | 1896 |
|
|
2023
Q3 | $25.7M | Buy |
784,444
+51,893
| +7% | +$1.7M | 0.01% | 1785 |
|
|
2023
Q2 | $25.8M | Sell |
732,551
-99,476
| -12% | -$3.5M | 0.01% | 1796 |
|
|
2023
Q1 | $27.2M | Buy |
832,027
+251,623
| +43% | +$8.22M | 0.01% | 1751 |
|
|
2022
Q4 | $32K | Buy |
580,404
+17,634
| +3% | +$972 | 0.01% | 1613 |
|
|
2022
Q3 | $24.9M | Buy |
562,770
+105,082
| +23% | +$4.65M | 0.01% | 1698 |
|
|
2022
Q2 | $22.3M | Buy |
457,688
+111,636
| +32% | +$5.44M | 0.01% | 1797 |
|
|
2022
Q1 | $16.8M | Buy |
346,052
+150,931
| +77% | +$7.34M | 0.01% | 2054 |
|
|
2021
Q4 | $8.32M | Buy |
195,121
+158,725
| +436% | +$6.77M | ﹤0.01% | 2376 |
|
|
2021
Q3 | $1.4M | Buy |
+36,396
| New | +$1.4M | ﹤0.01% | 2955 |
|